EP Patent

EP0232690A1 — Novel 16,17-acetalsubstituted pregnane-21-oic acid derivatives, process for the preparation thereof and pharmaceutical preparation containing them

Assigned to Draco AB · Expires 1987-08-19 · 39y expired

What this patent protects

The invention refers to compounds having activity against inflammatory, allergic, and dermatological conditions. The compounds are characterized by the formula or a stereoisomeric component thereof, in which formula R 1 is selected from a straight or branched hydrocarbon ch…

USPTO Abstract

The invention refers to compounds having activity against inflammatory, allergic, and dermatological conditions. The compounds are characterized by the formula or a stereoisomeric component thereof, in which formula R 1 is selected from a straight or branched hydrocarbon chain having 1-4 carbon atoms. The invention also refers to processes for the preparation of these compounds, pharmaceutical preparations containing one of the compounds and a method for the treatment of inflammatory, allergic, muscoskeletal and dermatological conditions.

Drugs covered by this patent

Patent Metadata

Patent number
EP0232690A1
Jurisdiction
EP
Classification
Expires
1987-08-19
Drug substance claim
No
Drug product claim
No
Assignee
Draco AB
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.